ArticleJAC-antimicrobial resistance2026
Antimicrobial resistance among people with intellectual disabilities in long-term care facilities: an exploratory, isolate-based surveillance study based on routine diagnostics between 2018 and 2023 in the Netherlands.
Article in JAC-antimicrobial resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Little is known about the presence of resistant micro-organisms in people with intellectual disabilities (ID) residing in long-term care facilities (LTCFs). We explored the resistant percentages of six highly resistant micro-organisms (HRMOs) among people with ID in ID-LTCFs: ESBL-producing Methods: We included data on the first isolate per species, per patient, per year ordered by ID physicians, as delivered by 11 clinical microbiology laboratories, participating in the Dutch National Infectious Diseases Surveillance Information System-Antimicrobial Resistance (ISIS-AR) between 2018 and 2023. Resistance was classified based on phenotypic and genotypic test results. The resistance percentage for each HRMO was calculated as the percentage of resistant isolates among the total number of isolates for each corresponding species. Results: The percentage of resistant ESBL-E isolates among Conclusions: The resistance percentages for six HRMOs among positive diagnostic isolates ordered by ID physicians for people with ID in the Netherlands are low. The majority of HRMOs detected were isolated from older adults with ID. To estimate the burden of AMR and associated risk factors in the whole ID population, more extensive studies, including data from other medical specialties serving people with ID, such as general practitioners, are needed.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.